<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Kotkowski E</submitter><funding>National Center for Advancing Translational Sciences</funding><funding>NCATS NIH HHS</funding><funding>NICHD NIH HHS</funding><funding>NIA NIH HHS</funding><funding>NIMH NIH HHS</funding><funding>National Institute of Mental Health</funding><funding>National Institutes of Health</funding><funding>NIH HHS</funding><funding>NIGMS NIH HHS</funding><pagination>295-299</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8005432</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(2)</volume><pubmed_abstract>The posterior cerebellum is the most significantly compromised brain structure in individuals with metabolic syndrome (MetS) (Hum Brain Mapp 40(12):3575-3588, 2019). In light of this, we hypothesized that cognitive decline reported in patients with MetS is likely related to posterior cerebellar atrophy. In this study, we performed a post hoc analyses using T1-weighted magnetic resonance imaging (MRI), diffusion tensor imaging (DTI) in the form of voxel-wise tract-based spatial statistics (TBSS), biometric, and psychometric data from young participants with (n = 52, aged 18-35 years) and without MetS (n = 52, aged 18-35 years). To test the predictive value of components of the Schmahmann syndrome scale (SSS), also known as the cerebellar cognitive affective syndrome scale, we used structura</pubmed_abstract><journal>Cerebellum (London, England)</journal><pubmed_title>Using the Schmahmann Syndrome Scale to Assess Cognitive Impairment in Young Adults with Metabolic Syndrome: a Hypothesis-Generating Report.</pubmed_title><pmcid>PMC8005432</pmcid><funding_grant_id>R01MH074457-11S1</funding_grant_id><funding_grant_id>T32GM113898</funding_grant_id><funding_grant_id>R01 MH074457</funding_grant_id><funding_grant_id>R01 AG058464</funding_grant_id><funding_grant_id>P50 HD105351</funding_grant_id><funding_grant_id>TL1 TR002647</funding_grant_id><funding_grant_id>TL1TR002647-01</funding_grant_id><funding_grant_id>T32 GM113896</funding_grant_id><funding_grant_id>R56 MH074457</funding_grant_id><pubmed_authors>Kotkowski E</pubmed_authors><pubmed_authors>Fox PT</pubmed_authors><pubmed_authors>DeFronzo RA</pubmed_authors><pubmed_authors>Blevins CJ</pubmed_authors><pubmed_authors>Schmahmann JD</pubmed_authors><pubmed_authors>Franklin CG</pubmed_authors><pubmed_authors>Blangero J</pubmed_authors><pubmed_authors>Glahn DC</pubmed_authors><pubmed_authors>Woolsey MD</pubmed_authors><pubmed_authors>Duggirala R</pubmed_authors><pubmed_authors>Price LR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Using the Schmahmann Syndrome Scale to Assess Cognitive Impairment in Young Adults with Metabolic Syndrome: a Hypothesis-Generating Report.</name><description>The posterior cerebellum is the most significantly compromised brain structure in individuals with metabolic syndrome (MetS) (Hum Brain Mapp 40(12):3575-3588, 2019). In light of this, we hypothesized that cognitive decline reported in patients with MetS is likely related to posterior cerebellar atrophy. In this study, we performed a post hoc analyses using T1-weighted magnetic resonance imaging (MRI), diffusion tensor imaging (DTI) in the form of voxel-wise tract-based spatial statistics (TBSS), biometric, and psychometric data from young participants with (n = 52, aged 18-35 years) and without MetS (n = 52, aged 18-35 years). To test the predictive value of components of the Schmahmann syndrome scale (SSS), also known as the cerebellar cognitive affective syndrome scale, we used structura</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-04-04T02:37:46.681Z</modification><creation>2024-11-15T21:01:36.016Z</creation></dates><accession>S-EPMC8005432</accession><cross_references><pubmed>33159660</pubmed><doi>10.1007/s12311-020-01212-9</doi></cross_references></HashMap>